Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2021-07-12 08:29 am Sale | 13G | PIERIS PHARMACEUTICALS INC PIRS | BlackRock Inc. BLK | 1,302,450 2.1% | -2,328,859 (-64.13%) | View |
| 2021-07-06 4:03 pm Purchase | 13G | PIERIS PHARMACEUTICALS INC PIRS | CITADEL ADVISORS LLC | 3,322,863 5.2% | 3,322,863 (New Position) | View |
| 2021-04-07 5:37 pm Purchase | 13G | PIERIS PHARMACEUTICALS INC PIRS | ASTRAZENECA PLC AZN | 3,584,230 5.66% | 3,584,230 (New Position) | View |
| 2021-04-02 4:20 pm Purchase | 13G | PIERIS PHARMACEUTICALS INC PIRS | Seagen Inc. SGEN | 3,706,174 6.2% | 3,706,174 (New Position) | View |
| 2021-02-16 4:13 pm Sale | 13G | PIERIS PHARMACEUTICALS INC PIRS | Aquilo Capital Management LLC | 4,802,291 8.4% | -773,239 (-13.87%) | View |
| 2021-02-16 07:31 am Purchase | 13G | PIERIS PHARMACEUTICALS INC PIRS | Nussbaum Ran | 3,571,428 6.4% | 3,571,428 (New Position) | View |
| 2021-02-12 4:20 pm Sale | 13G | PIERIS PHARMACEUTICALS INC PIRS | BIOTECHNOLOGY VALUE FUND L P | 5,601,582 9.99% | -271,180 (-4.62%) | View |
| 2021-01-29 5:23 pm Purchase | 13G | PIERIS PHARMACEUTICALS INC PIRS | BlackRock Inc. BLK | 3,631,309 6.5% | 226,184 (+6.64%) | View |
| 2020-04-21 7:42 pm Purchase | 13G | PIERIS PHARMACEUTICALS INC PIRS | Aquilo Capital Management LLC | 5,575,530 10.1% | 25,165 (+0.45%) | View |
| 2020-02-19 4:32 pm Purchase | 13G | PIERIS PHARMACEUTICALS INC PIRS | BIOTECHNOLOGY VALUE FUND L P | 5,872,762 10.7% | 365,857 (+6.64%) | View |
| 2020-02-14 4:03 pm Sale | 13G | PIERIS PHARMACEUTICALS INC PIRS | BIOTECHNOLOGY VALUE FUND L P | 5,506,905 9.99% | -1,951,016 (-26.16%) | View |
| 2020-02-14 2:59 pm Purchase | 13G | PIERIS PHARMACEUTICALS INC PIRS | Aquilo Capital Management LLC | 5,550,365 9.9% | 2,649,929 (+91.36%) | View |
| 2020-02-07 08:45 am Purchase | 13G | PIERIS PHARMACEUTICALS INC PIRS | BlackRock Inc. BLK | 3,405,125 6.2% | 3,405,125 (New Position) | View |
| 2019-11-14 4:45 pm Purchase | 13G | PIERIS PHARMACEUTICALS INC PIRS | EcoR1 Capital LLC | 5,070,424 8.8% | 5,070,424 (New Position) | View |
| 2019-10-07 4:04 pm Purchase | 13G | PIERIS PHARMACEUTICALS INC PIRS | Aquilo Capital Management LLC | 2,900,436 5.9% | 2,900,436 (New Position) | View |